Aurinia Pharmaceuticals (FRA:IKAP) Accounts Payable & Accrued Expense : €43.1 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Aurinia Pharmaceuticals Accounts Payable & Accrued Expense?

Aurinia Pharmaceuticals's quarterly accounts payable & accrued expense increased from Sep. 2024 (€51.9 Mil) to Dec. 2024 (€67.0 Mil) but then declined from Dec. 2024 (€67.0 Mil) to Mar. 2025 (€43.1 Mil).

Aurinia Pharmaceuticals's annual accounts payable & accrued expense increased from Dec. 2022 (€37.8 Mil) to Dec. 2023 (€50.6 Mil) and increased from Dec. 2023 (€50.6 Mil) to Dec. 2024 (€67.0 Mil).

Aurinia Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Aurinia Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurinia Pharmaceuticals Accounts Payable & Accrued Expense Chart

Aurinia Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

20.38

30.93

37.75

50.61

67.00

Aurinia Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															46.25	52.45	51.87	67.00	43.08

Aurinia Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Aurinia Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurinia Pharmaceuticals Inc (FRA:IKAP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

AUPH:USA IKAP:Germany

Address

14315 - 118 Avenue, Suite 140, Edmonton, AB, CAN, T5L 4S6

Website

https://www.auriniapharma.com

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Aurinia Pharmaceuticals Headlines

No Headlines